SCHEMBL4568600

SCHEMBL4568600

N#Cc1ccc(Nc2nc(Oc3ccc(Br)cc3)c3ccccc3n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 6/20 0.51
MERTK Q12866 2/20 0.49
ACP1 P24666 1/20 0.46
MAPT P10636 4/20 0.45
KMT2A Q03164 3/20 0.45
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
HTT P42858 1/20 0.45
ABCB1 P08183 2/20 0.45
KCNH2 Q12809 2/20 0.45
SCN5A Q14524 1/20 0.45
SCN9A Q15858 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MAPK1 P28482 2/20 0.44
MEN1 O00255 1/20 0.44
TP53 P04637 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ABCC3 O15438 1/20 0.44
ESR1 P03372 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4568602 0.92 MERTK (0.54) ABCG2MERTKACP1MAPTKMT2A
SCHEMBL4568601 0.89 MAPT (0.59) MERTKACP1MAPTKMT2AALDH1A1
SCHEMBL4568604 0.89 NPY5R (0.52) ABCG2MERTKACP1MAPTKMT2A
SCHEMBL4568611 0.81 MAPT (0.50) ABCG2MERTKACP1MAPTKMT2A
SCHEMBL4568599 0.81 MERTK (0.50) ABCG2MERTKACP1MAPTKMT2A
SCHEMBL4568615 0.81 MERTK (0.50) ABCG2MERTKACP1MAPTKMT2A
SCHEMBL4568605 0.80 ABCG2 (0.56) ABCG2MERTKACP1MAPTKMT2A
SCHEMBL8898863 0.74 NPY5R (0.74) ABCG2MERTKMAPTKMT2AALDH1A1
SCHEMBL7420353 0.74 SMN1; SMN2 (0.64) ABCG2MERTKACP1MAPTKMT2A
Hydrochloric Acid SCHEMBL8890746 0.74 NPY5R (0.77) ABCG2MERTKACP1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809343-B2 Pyrimidine derivative, preparation method and use thereof FUDAN UNIVERSITY (CN) 2014-08-19 US disclosed
US-8809343-B2 Pyrimidine derivative, preparation method and use thereof FUDAN UNIVERSITY (CN) 2014-08-19 US disclosed
US-20120122902-A1 PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF FUDAN UNIVERSITY (CN) 2012-05-17 US disclosed
US-20120122902-A1 PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF FUDAN UNIVERSITY (CN) 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122902-A1 PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF DPYD, TYMP, TYMS ABCG2 136/4885MERTK 3234/4885ACP1 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.